Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Leukotriene B4 and Ebselen

supplement:

Ebselen

Research Papers that Mention the Interaction

In the present report we demonstrate that ebselen specifically inhibits the formation of LTB4 at lower concentrations than those at which it influences the production of 5-HPETE and LTA4.
Agents and Actions  •  2005  |  View Paper
Ebselen , a new organoselenium compound with pronounced anti-inflammatory properties, selectively inhibits the formation of leukotriene B4 in human and porcine leukocytes with half-maximal inhibition at 4.0 and 2.7 mumol/1, respectively.
Prostaglandins  •  1986  |  View Paper
Ebselen at 3–20 μM concentrations inhibited both chemotactic and chemokinetic responses to optimal concentrations of LTB4 without altering chemotactic responses to C5a or fMLP.
Agents and Actions  •  2005  |  View Paper
Both reactive oxygen species [24] and LTB4 [51, 52] enhance granulocyte adhesiveness to endothelium and ebselen inhibits the generation of reactive oxygen species, catalyses the breakdown of hydroperoxides, inactivates LTB4 by isomerization and inhibits 5-lipoxygenase [9–11, 13–16, 27–29].
Agents and Actions  •  2005  |  View Paper
In addition, ebselen also inactivates leukotriene B4 (LTB4) generated by pig leukocytes in vitro by isomerizing this eicosanoid to its biologically inactive 6-trans isomer.
International journal of tissue reactions  •  1987  |  View Paper
When ethanolic extracts of the medium of stimulated cells were analysed by HPLC, a dose-dependent inhibition by ebselen of LTB4 formation with a concomitant decrease of 5-HETE production was found.
Biochemical pharmacology  •  1985  |  View Paper